| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.06. | Symeres Expands Spray Drying Capabilities in Cranbury, NJ | ||
| 10.06. | FibroFind Names New CEO, Adds Three Senior Hires | ||
| 10.06. | Lonza Appoints Hans Trees as Global Head of Communications | ||
| 10.06. | Sanofi Halts MOBILIZE Phase 3 Study of Riliprubart | ||
| 10.06. | FDA Approves EBGLYSS 8-Week Dosing | ||
| 10.06. | Orionis Biosciences, Novartis Partner to Advance Molecular Glue Drugs | ||
| 09.06. | CatalYm Announces New Chief Financial Officer Peter Garcia | ||
| 09.06. | Syntax Bio Pairs With Mayo Clinic on Stem-Cell Pancreatic Cell Therapies for Type 1 Diabetes | ||
| 09.06. | Syntis Bio Taps Matthew Dallas as CFO | ||
| 09.06. | GSK Agrees to Acquire Nuvalent for $10.6B | ||
| 08.06. | AdvanCell Names New CTO and CSO, Expanding Executive Leadership Team | ||
| 08.06. | Shilpa Medicare, Gate2Brain Partner to Advance First-in-Class Brain Cancer Therapy | ||
| 08.06. | J&J Agrees to Acquire Firefly Bio for $1B | ||
| 08.06. | Pfizer's Hympavzi Gets FDA Approval for Expanded Indication | ||
| 08.06. | Roche Strikes $2.3B Nurix Deal for BTK Degrader | ||
| 08.06. | Stevanato Group Introduces New Proprietary Pen Injector Platform | ||
| 08.06. | Barentz Opens New Office in Chesterbrook, PA | ||
| 08.06. | Apnimed Appoints Kevin Lind as CEO | ||
| 08.06. | Incyte Agrees to Acquire Vega Therapeutics for $1.25B | ||
| 05.06. | Sanofi Inks Five-Year Pact to License Owkin's AI Scientist K Pro for Next-Gen Biopharma Agents | ||
| 05.06. | WuXi Biologics Tops Out Modular Drug Product Facility in Singapore | ||
| 05.06. | Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines | ||
| 04.06. | Haga Bioscience Closes $2.3M Funding Round to Commercialize Spatial Biology Tech | ||
| 04.06. | Massive Bio, Optellum Partner on Early Detection, Clinical Trial Access for Lung Cancer | ||
| 04.06. | Travere Therapeutics, Everest Medicines Partner to Advance Civorebrutinib |